Correlation Between Ubiquitech Software and Blueberries Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ubiquitech Software and Blueberries Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubiquitech Software and Blueberries Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ubiquitech Software and Blueberries Medical Corp, you can compare the effects of market volatilities on Ubiquitech Software and Blueberries Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubiquitech Software with a short position of Blueberries Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubiquitech Software and Blueberries Medical.

Diversification Opportunities for Ubiquitech Software and Blueberries Medical

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Ubiquitech and Blueberries is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Ubiquitech Software and Blueberries Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueberries Medical Corp and Ubiquitech Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubiquitech Software are associated (or correlated) with Blueberries Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueberries Medical Corp has no effect on the direction of Ubiquitech Software i.e., Ubiquitech Software and Blueberries Medical go up and down completely randomly.

Pair Corralation between Ubiquitech Software and Blueberries Medical

Given the investment horizon of 90 days Ubiquitech Software is expected to generate 32.4 times more return on investment than Blueberries Medical. However, Ubiquitech Software is 32.4 times more volatile than Blueberries Medical Corp. It trades about 0.33 of its potential returns per unit of risk. Blueberries Medical Corp is currently generating about 0.01 per unit of risk. If you would invest  0.01  in Ubiquitech Software on September 20, 2024 and sell it today you would earn a total of  0.00  from holding Ubiquitech Software or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ubiquitech Software  vs.  Blueberries Medical Corp

 Performance 
       Timeline  
Ubiquitech Software 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ubiquitech Software are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ubiquitech Software unveiled solid returns over the last few months and may actually be approaching a breakup point.
Blueberries Medical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Blueberries Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, Blueberries Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ubiquitech Software and Blueberries Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ubiquitech Software and Blueberries Medical

The main advantage of trading using opposite Ubiquitech Software and Blueberries Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubiquitech Software position performs unexpectedly, Blueberries Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueberries Medical will offset losses from the drop in Blueberries Medical's long position.
The idea behind Ubiquitech Software and Blueberries Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance